6.
Braun-Walicka N, Pluta A, Wolak T, Maj E, Maryniak A, Gos M
. Research on the Pathogenesis of Cognitive and Neurofunctional Impairments in Patients with Noonan Syndrome: The Role of Rat Sarcoma-Mitogen Activated Protein Kinase Signaling Pathway Gene Disturbances. Genes (Basel). 2023; 14(12).
PMC: 10742480.
DOI: 10.3390/genes14122173.
View
7.
Orekhova E, Manyukhina V, Galuta I, Prokofyev A, Goiaeva D, Obukhova T
. Gamma oscillations point to the role of primary visual cortex in atypical motion processing in autism. PLoS One. 2023; 18(2):e0281531.
PMC: 9925089.
DOI: 10.1371/journal.pone.0281531.
View
8.
Crow A, Janssen J, Marshall C, Moffit A, Brennan L, Kohler C
. A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1. Am J Med Genet A. 2022; 188(8):2277-2292.
PMC: 9302478.
DOI: 10.1002/ajmg.a.62773.
View
9.
Anastasaki C, Wegscheid M, Hartigan K, Papke J, Kopp N, Chen J
. Human iPSC-Derived Neurons and Cerebral Organoids Establish Differential Effects of Germline NF1 Gene Mutations. Stem Cell Reports. 2020; 14(4):541-550.
PMC: 7160375.
DOI: 10.1016/j.stemcr.2020.03.007.
View
10.
Bruno J, Shrestha S, Reiss A, Saggar M, Green T
. Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway. Mol Psychiatry. 2022; 27(3):1542-1551.
PMC: 9106817.
DOI: 10.1038/s41380-021-01422-5.
View
11.
Ribeiro M, dAlmeida O, Ramos F, Saraiva J, Silva E, Castelo-Branco M
. Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits. J Neurodev Disord. 2014; 6(1):4.
PMC: 3944002.
DOI: 10.1186/1866-1955-6-4.
View
12.
Pierpont E, Weismer S, Roberts A, Tworog-Dube E, Pierpont M, Mendelsohn N
. The language phenotype of children and adolescents with Noonan syndrome. J Speech Lang Hear Res. 2010; 53(4):917-32.
PMC: 3086511.
DOI: 10.1044/1092-4388(2009/09-0046).
View
13.
Wen Y, Alshikho M, Herbert M
. Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling. PLoS One. 2016; 11(4):e0153329.
PMC: 4824422.
DOI: 10.1371/journal.pone.0153329.
View
14.
Omrani A, van der Vaart T, Mientjes E, van Woerden G, Hojjati M, Li K
. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. Mol Psychiatry. 2015; 20(11):1311-21.
PMC: 5603719.
DOI: 10.1038/mp.2015.48.
View
15.
Ottenhoff M, Rietman A, Mous S, Plasschaert E, Gawehns D, Brems H
. Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1. Genet Med. 2020; 22(5):889-897.
PMC: 7200599.
DOI: 10.1038/s41436-020-0752-2.
View
16.
Violante I, Ribeiro M, Silva E, Castelo-Branco M
. Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities. J Neurodev Disord. 2013; 5(1):3.
PMC: 3599251.
DOI: 10.1186/1866-1955-5-3.
View
17.
Silva G, Duarte I, Bernardino I, Marques T, Violante I, Castelo-Branco M
. Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study. J Neurodev Disord. 2018; 10(1):11.
PMC: 5863896.
DOI: 10.1186/s11689-018-9230-4.
View
18.
Weiss B, Wolters P, Plotkin S, Widemann B, Tonsgard J, Blakeley J
. NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. J Clin Oncol. 2021; 39(7):797-806.
PMC: 8078274.
DOI: 10.1200/JCO.20.02220.
View
19.
Filippi C, Watts R, Duy L, Cauley K
. Diffusion-tensor imaging derived metrics of the corpus callosum in children with neurofibromatosis type I. AJR Am J Roentgenol. 2012; 200(1):44-9.
DOI: 10.2214/AJR.12.9590.
View
20.
Huijbregts S, Loitfelder M, Rombouts S, Swaab H, Verbist B, Arkink E
. Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms. J Neurodev Disord. 2015; 7:32.
PMC: 4607002.
DOI: 10.1186/s11689-015-9128-3.
View